TrialEpilepsia2022

Time to onset of cannabidiol treatment effect and resolution of adverse events in tuberous sclerosis complex: Post hoc analysis of randomized controlled phase 3 trial GWPCARE6.

Joyce Y Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.